Clara Ugolini
University of Pisa(IT)Azienda Ospedaliera Universitaria Pisana(IT)
Publications by Year
Research Areas
Thyroid Cancer Diagnosis and Treatment, Genetic factors in colorectal cancer, Colorectal Cancer Treatments and Studies, BRCA gene mutations in cancer, Thyroid and Parathyroid Surgery
Most-Cited Works
- → BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study(2008)526 cited
- → Association of BRAF V600E Mutation with Poor Clinicopathological Outcomes in 500 Consecutive Cases of Papillary Thyroid Carcinoma(2007)393 cited
- → Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial(2020)314 cited
- → Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial(2022)251 cited
- → Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role(2009)248 cited
- → TheBRAFV600E Mutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study